CagriSema analyses show 25% weight loss in women as Novo loses bid to halt Lilly ads

More peptides

1. New research finds GLP-1 users spend less on alcohol, which could dent beer sales

   

   P@phl17 Oct 28

   peptides typeshitResearch

   New research finds GLP-1 users spend less on alcohol, which could dent beer sales

   PHL17 shares findings that people on Ozempic and similar drugs are cutting alcohol spending at bars, restaurants and home.

   See it on Instagram
2. Omer Raheem presents GLP-1 research beyond weight loss at an ISSM webinar

   

   OROmer Raheem Oct 28

   peptides typeshitResearch

   Omer Raheem presents GLP-1 research beyond weight loss at an ISSM webinar

   Omer Raheem says he presented his team's work on GLP-1 therapies past weight loss at the ISSM Journals Webinar 2026.

   See it on X
3. Quartz looks at next-wave weight loss drugs from six companies after Wegovy and Zepbound

   

   QCqz.com Oct 28

   peptides typeshitResearch

   Quartz looks at next-wave weight loss drugs from six companies after Wegovy and Zepbound

   The rundown covers CagriSema, retatrutide, MariTide, VK2735 and Roche's enicepatide, which the company says cut weight by 15.5% on average in a mid-stage trial.

   Read at qz.com
4. Alex Zhavoronkov shares ARDD 2026 talks, including Lilly on tirzepatide and aging clocks

   

   AZAlex Zhavoronkov, PhD (aka Aleksandrs Zavoronkovs) Oct 28

   peptides typeshitResearch

   Alex Zhavoronkov shares ARDD 2026 talks, including Lilly on tirzepatide and aging clocks

   Zhavoronkov links recorded ARDD 2026 sessions, among them Lilly's Kevin Duffin speaking on tirzepatide and aging clocks.

   See it on X
5. Interest in one GLP-1 side effect seems driven by social media speculation

   

   FFacebook Oct 27

   peptides typeshitSafety

   Interest in one GLP-1 side effect seems driven by social media speculation

   A Facebook post links to a story saying curiosity about a particular GLP-1 side effect traces back to speculation online. The side effect isn't named.

   See it on Facebook
6. NYC plastic surgeon Anna Steve says over 80% of her patients are on a GLP-1

   

   N@newbeauty Oct 27

   peptides typeshitNews

   NYC plastic surgeon Anna Steve says over 80% of her patients are on a GLP-1

   NewBeauty talks with New York plastic surgeon Dr. Anna Steve about how common GLP-1 use has become among the people coming to her practice.

   See it on Instagram